雌激素影响下野生型MED12子宫肌瘤中促红细胞生成素信使核糖核酸的表达:对相关生长差异的新见解
研究分析108例子宫肌瘤患者组织中促红细胞生成素(EPO)信使核糖核酸(mRNA)表达与MED12突变及HMGA1/HMGA2表达的关系,并用原代培养肌瘤细胞评估雌二醇(E2)对EPO mRNA的影响。野生型MED12肌瘤EPO mRNA水平为突变型的三倍;仅野生型MED12肌瘤在E2处理后EPO mRNA表达增加两倍,突变型不受影响。
要点
- 野生型MED12子宫肌瘤EPO mRNA水平为突变型的三倍
- EPO mRNA与HMGA1或HMGA2 mRNA表达水平无相关性
- 仅野生型MED12肌瘤在E2处理后EPO mRNA表达增加两倍
核心结论
- 仅在缺乏MED12突变的子宫肌瘤中,E2处理使EPO mRNA表达显著增加。
- 结合既往EPO mRNA表达水平与肿瘤大小相关的证据,E2刺激的EPO mRNA表达可能解释这些肿瘤中明显的生长差异。
研究设计与样本
- 分析108例子宫肌瘤患者组织样本和临床数据中EPO mRNA表达与MED12突变的关系。
- 另收集10例子宫肌瘤患者组织样本,用原代培养的子宫肌瘤和子宫肌层细胞进行体外实验,评估10-8 M 17β-E2对EPO mRNA表达的影响。
主要发现
- 野生型MED12子宫肌瘤的EPO mRNA水平为突变型的三倍。
- EPO与HMGA1或HMGA2 mRNA表达水平之间无相关性。
- 仅在野生型MED12子宫肌瘤中,E2处理使EPO mRNA表达增加两倍,而突变型MED12子宫肌瘤不受影响。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine factors that impact erythropoietin (EPO) production in leiomyomas. We have previously implicated EPO production in promoting the growth of some leiomyomas. DESIGN: The relationship between EPO messenger RNA (mRNA) expression and MED12 gene mutations or mRNA expression levels of high-mobility group AT-hook (HMGA) 1 and HMGA2 were analyzed. Effects of 10-8 M 17β-E2 on EPO mRNA expression were evaluated using leiomyoma cells grown in primary cultures. SETTING: Graduate school of medicine. PATIENT(S): Patients with leiomyoma. INTERVENTION(S): We used tissue samples and clinical data of 108 patients with leiomyomas to analyze the relation between EPO mRNA expression and MED12 mutation. Tissue samples from another 10 patients with leiomyomas were collected for in vitro experimentation using primary cultures of leiomyoma and myometrial cells. MAIN OUTCOME MEASURE(S): Relations between EPO mRNA expression, MED12 exon 2 mutation, and HMGA1/HMGA2 mRNA expression levels in leiomyoma samplings, in addition to effects of estrogen (E) on EPO mRNA expression in cultures of leiomyoma cells. RESULT(S): The EPO mRNA level was threefold higher in leiomyomas with wild-type (vs. mutated) MED12 genes. There was no correlation between EPO and HMGA1 or HMGA2 mRNA expression levels. In wild-type MED12 leiomyomas only, E2 treatment produced a twofold increase in EPO mRNA expression, whereas mutated MED12 leiomyomas were unaffected. CONCLUSION(S): The EPO mRNA expression increased significantly after E2 treatment only in leiomyomas lacking MED12 mutations. In conjunction with prior evidence linking EPO mRNA expression levels and tumor size, E2-stimulated EPO mRNA expression may explain the marked growth disparities seen in these tumors.
引用
- Asano R, Asai-Sato M, Matsukuma S, et al. Expression of erythropoietin messenger ribonucleic acid in wild-type MED12 uterine leiomyomas under estrogenic influence: new insights into related growth disparities. Fertil Steril. 2018. PMID: 30554729. doi:10.1016/j.fertnstert.2018.09.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。